Cocrystal Pharma Inc (NASDAQ:COCP)
| 1.70 Delayed Data As of 3:40pm ET |  +0.015 / +0.89%Today’s Change | 1.38 Today|||52-Week Range 3.29 | -12.82% Year-to-Date |
Latest COCP News | Press Releases
No recent news for Cocrystal Pharma Inc.
Today’s Trading
| Previous close | 1.69 |
| Today’s open | 1.66 |
| Day’s range | 1.66 - 1.70 |
| Volume | 57 |
| Average volume (3 months) | 28,269 |
| Market cap | $18.9M |
Data as of 3:40pm ET, 12/06/2023
Growth & Valuation
| Earnings growth (last year) | -2,871.59% |
| Earnings growth (this year) | +49.48% |
| Earnings growth (next 5 years) | -- |
| Revenue growth (last year) | -- |
| P/E ratio | NM |
| Price/Sales | -- |
| Price/Book | 0.38 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| SSKNSTRATA Skin Sciences... | +0.03 | +5.69% |
| MBRXMoleculin Biotech In... | 0.00 | 0.00% |
| ---- | ||
| MTEXMannatech Inc | +0.01 | +0.11% |
Data as of 3:59pm ET, 12/06/2023
Financials
| Next reporting date | March 21, 2024 |
| EPS forecast (this quarter) | -$0.60 |
| Annual revenue (last year) | $0.00 |
| Annual profit (last year) | -$38.8M |
| Net profit margin | -- |
Profile
Sector Health Technology |
Industry Pharmaceuticals: Major |
No executives to display |
Corporate headquarters Bothell, Washington |
Forecasts
